Dow Up 0.35% Nasdaq Down 0.02%

Theravance Inc. (THRX)

-NasdaqGS
22.76 0.54(2.32%) Aug 20, 4:00PM EDT
Prev Close:23.30
Open:23.17
Bid:22.42 x 500
Ask:29.93 x 100
1y Target Est:29.86
Beta:0.63
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:22.71 - 23.31
52wk Range:20.23 - 34.53
Volume:346,769
Avg Vol (3m):1,159,810
Market Cap:2.62B
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXDown 2.32%2.62B
AZN89.67B
CBST4.91B
PFE183.19B

Key Statistics

Forward P/E (1 yr):227.60
P/S (ttm):1,181.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback